Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
430.11
Dollar change
+3.33
Percentage change
0.78
%
IndexNDX, S&P 500 P/E30.96 EPS (ttm)13.89 Insider Own0.42% Shs Outstand257.70M Perf Week0.90%
Market Cap111.10B Forward P/E23.35 EPS next Y18.42 Insider Trans-13.99% Shs Float257.21M Perf Month0.60%
Income3.62B PEG2.39 EPS next Q4.03 Inst Own92.85% Short Float1.29% Perf Quarter21.23%
Sales9.84B P/S11.29 EPS this Y10.24% Inst Trans1.21% Short Ratio2.17 Perf Half Y22.68%
Book/sh68.22 P/B6.30 EPS next Y9.72% ROA17.56% Short Interest3.31M Perf Year46.12%
Cash/sh43.44 P/C9.90 EPS next 5Y12.97% ROE22.99% 52W Range283.60 - 448.40 Perf YTD5.71%
Dividend Est.- P/FCF33.29 EPS past 5Y11.42% ROI19.77% 52W High-4.08% Beta0.36
Dividend TTM- Quick Ratio3.78 Sales past 5Y27.16% Gross Margin87.17% 52W Low51.66% ATR (14)8.63
Dividend Ex-Date- Current Ratio3.99 EPS Y/Y TTM8.28% Oper. Margin38.33% RSI (14)56.66 Volatility1.88% 2.03%
Employees5400 Debt/Eq0.05 Sales Y/Y TTM12.47% Profit Margin36.79% Recom1.97 Target Price463.81
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q18.03% Payout0.00% Rel Volume0.49 Prev Close426.78
Sales Surprise0.19% EPS Surprise3.27% Sales Q/Q12.00% EarningsFeb 05 AMC Avg Volume1.52M Price430.11
SMA201.06% SMA502.79% SMA20016.91% Trades Volume746,936 Change0.78%
Date Action Analyst Rating Change Price Target Change
Feb-15-24Initiated Wolfe Research Outperform $515
Feb-06-24Downgrade Evercore ISI Outperform → In-line $436 → $438
Feb-02-24Downgrade Bernstein Outperform → Mkt Perform
Jan-31-24Downgrade Robert W. Baird Neutral → Underperform $325
Jan-31-24Downgrade Maxim Group Buy → Hold
Jan-24-24Downgrade Canaccord Genuity Hold → Sell $332 → $379
Dec-14-23Reiterated RBC Capital Mkts Sector Perform $347 → $379
May-30-23Initiated William Blair Outperform $382
May-04-23Resumed Piper Sandler Overweight $385
Mar-21-23Initiated Bernstein Outperform $344
Today 08:00AM
Feb-23-24 05:00PM
01:42PM
07:10AM
05:50AM
05:43AM Loading…
05:43AM
Feb-22-24 03:02PM
Feb-21-24 05:00PM
Feb-20-24 04:05PM
05:35AM
05:02AM
Feb-19-24 10:15AM
01:45AM
Feb-18-24 09:10AM
05:07AM
12:45AM Loading…
12:45AM
Feb-17-24 02:25PM
10:00AM
Feb-16-24 12:06AM
Feb-15-24 02:36PM
07:15AM
05:50AM
02:05AM
Feb-14-24 05:05AM
04:30AM
Feb-13-24 09:45AM
01:59AM
Feb-12-24 09:45AM
Feb-10-24 12:37PM
09:45AM
08:30AM Loading…
08:30AM
08:30AM
06:49AM
05:04AM
Feb-09-24 08:00AM
06:48AM
Feb-08-24 12:20PM
09:53AM
Feb-06-24 04:07PM
10:26AM
09:53AM
08:36AM
08:00AM
05:15AM
Feb-05-24 11:30PM
05:20PM
04:59PM
04:19PM
04:13PM
04:06PM
04:01PM
Feb-02-24 04:12PM
10:47AM
Jan-31-24 12:18PM
09:53AM
09:15AM
Jan-30-24 07:10PM
04:06PM
11:44AM
10:49AM
09:41AM
06:53AM
06:34AM
06:30AM
06:28AM
05:02AM
Jan-29-24 05:50PM
Jan-27-24 11:50AM
07:54AM
Jan-25-24 12:00PM
09:45AM
Jan-24-24 09:45AM
09:30AM
05:15AM
Jan-23-24 05:50PM
09:30AM
Jan-22-24 02:23PM
11:02AM
09:00AM
05:05AM
Jan-21-24 07:15AM
Jan-20-24 12:50PM
06:55AM
06:50AM
Jan-17-24 05:50PM
12:04PM
08:00AM
05:50AM
Jan-16-24 04:08PM
03:02PM
02:24PM
Jan-15-24 05:19AM
Jan-14-24 01:30PM
10:13AM
09:00AM
Jan-13-24 07:48AM
Jan-10-24 04:45PM
06:55AM
05:51AM
Jan-09-24 05:50PM
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arbuckle Stuart AEVP, COOFeb 21Sale421.773,6031,519,63759,439Feb 23 04:12 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 21Sale421.773,1911,345,86860,798Feb 23 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 21Sale421.773,0021,266,15434,022Feb 23 04:10 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 21Sale421.771,201506,54618,509Feb 23 04:16 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 21Sale421.77360151,83759,467Feb 23 04:28 PM
Arbuckle Stuart AEVP, COOFeb 20Sale420.794,8042,021,47563,042Feb 21 04:19 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 20Sale420.794,2541,790,04163,989Feb 21 04:38 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 20Sale420.794,0021,684,00237,024Feb 21 04:13 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 20Sale420.79801337,05319,710Feb 21 04:23 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 20Sale420.79480201,97959,827Feb 21 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 15Sale419.164,6551,951,19017,896Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 14Sale419.044,3561,825,33822,551Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 13Sale419.13737308,89926,907Feb 14 04:04 PM
Arbuckle Stuart AEVP, COOFeb 12Sale420.244,2951,804,93175,718Feb 13 04:51 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 12Sale420.243,2221,354,01374,364Feb 13 05:15 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 12Sale420.243,1451,321,65547,588Feb 13 04:46 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 12Sale419.512,6561,114,20527,644Feb 14 04:04 PM
Biller JonathanEVP and Chief Legal OfficerFeb 12Sale418.771,738727,82218,280Feb 13 04:56 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 12Sale420.241,374577,4109,676Feb 13 04:48 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 12Sale420.24913383,67923,137Feb 13 04:54 PM
LEIDEN JEFFREY MExecutive ChairmanJan 08Sale419.076,6482,785,9772,423Jan 10 04:06 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJan 02Sale405.003,0001,215,00043,693Jan 04 04:17 PM
Kewalramani ReshmaCEO & PresidentDec 15Option Exercise181.8317,1353,115,593125,846Dec 19 04:15 PM
Kewalramani ReshmaCEO & PresidentDec 15Sale407.0017,1356,973,945108,711Dec 19 04:15 PM
Arbuckle Stuart AEVP, COODec 13Option Exercise187.538,6031,613,32165,159Dec 15 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanDec 13Sale399.4213,3545,333,7999,071Dec 15 04:33 PM
Arbuckle Stuart AEVP, COODec 13Sale399.008,6033,432,59756,556Dec 15 04:20 PM
Kewalramani ReshmaCEO & PresidentDec 13Sale397.005,0982,023,906108,711Dec 15 04:23 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerNov 20Sale349.883,0001,049,64046,693Nov 21 04:07 PM
Sachdev AmitEVP Chief Patient & Ext Af OffNov 15Sale369.923512,94758,814Nov 17 04:16 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 15Sale369.92197,02832,038Nov 17 04:11 PM
Bozic CarmenEVP and CMONov 14Sale380.825,6502,151,63329,302Nov 16 04:15 PM
Kewalramani ReshmaCEO & PresidentNov 13Sale377.005,0971,921,569113,809Nov 15 04:16 PM
SACHS BRUCE IDirectorNov 06Option Exercise127.5411,2501,434,82551,250Nov 08 04:11 PM
SACHS BRUCE IDirectorNov 06Sale385.0011,2504,331,25040,000Nov 08 04:11 PM
Bozic CarmenEVP and CMOOct 31Sale355.925,6512,011,30434,952Nov 02 04:07 PM
Bozic CarmenEVP and CMOOct 17Sale373.255,6512,109,23640,603Oct 19 04:18 PM
Bhatia Sangeeta N.DirectorOct 17Sale375.0024391,1253,901Oct 19 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanOct 16Sale374.0012,9624,847,78822,425Oct 18 04:17 PM
Bhatia Sangeeta N.DirectorOct 06Sale360.0024287,1204,144Oct 11 04:14 PM
Bozic CarmenEVP and CMOOct 03Sale345.285,6511,951,17746,254Oct 05 04:30 PM
Biller JonathanEVP and Chief Legal OfficerOct 02Sale346.76610211,52410,569Oct 03 04:07 PM
Bozic CarmenEVP and CMOSep 19Sale351.005,6511,983,50151,905Sep 21 04:15 PM
Bozic CarmenEVP and CMOSep 05Sale352.665,6511,992,88257,556Sep 07 04:29 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 23Sale355.002,500887,50048,637Aug 25 04:14 PM
Kearney Terrence CDirectorAug 10Option Exercise127.5410,0001,275,40016,536Aug 14 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerAug 10Sale350.0010,0313,510,85058,814Aug 14 04:05 PM
Kearney Terrence CDirectorAug 10Sale350.0010,0003,500,0006,536Aug 14 04:09 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 10Sale345.795,7501,988,29351,137Aug 14 04:08 PM
Bhatia Sangeeta N.DirectorAug 09Sale345.5124283,6134,386Aug 11 04:05 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 09Sale345.516321,76732,038Aug 11 04:05 PM
SACHS BRUCE IDirectorJul 17Option Exercise127.5411,2501,434,82551,250Jul 18 04:17 PM
SACHS BRUCE IDirectorJul 17Sale356.7511,2504,013,45940,000Jul 18 04:17 PM
Kewalramani ReshmaCEO & PresidentJul 17Sale355.007,8282,778,940118,906Jul 18 04:13 PM
Arbuckle Stuart AEVP, COOJun 15Option Exercise187.538,6031,613,32165,159Jun 20 04:07 PM
Arbuckle Stuart AEVP, COOJun 15Sale349.008,6033,002,44756,556Jun 20 04:07 PM
Ambrose KristenSVP & Chief Accounting OfficerMay 30Sale329.8228995,3186,838Jun 01 04:12 PM
Arbuckle Stuart AEVP, COOMay 30Sale329.828227,04556,556Jun 01 04:16 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 08Sale350.002,850997,50032,038May 09 04:15 PM
LEIDEN JEFFREY MExecutive ChairmanMay 08Sale349.001,125392,62535,387May 09 04:10 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Sale349.56879307,26236,512May 09 04:10 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 05Sale350.03422147,71334,888May 09 04:15 PM
LEIDEN JEFFREY MExecutive ChairmanMay 03Sale350.114,5081,578,30137,391May 04 04:50 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 03Sale350.742,781975,41835,310May 04 04:51 PM
LEIDEN JEFFREY MExecutive ChairmanMay 02Sale349.896,4502,256,76141,899May 04 04:50 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMay 02Sale350.661,622568,76838,091May 04 04:51 PM
Bhatia Sangeeta N.DirectorMay 02Sale348.28580202,0044,628May 03 04:44 PM
Kewalramani ReshmaCEO & PresidentApr 27Sale339.083,3171,124,726126,652May 01 04:26 PM
SACHS BRUCE IDirectorApr 12Option Exercise72.1421,3001,536,58262,510Apr 14 04:14 PM
SACHS BRUCE IDirectorApr 12Sale326.7321,3006,959,42241,210Apr 14 04:14 PM
Sanna BastianoEVP, Cell & Genetic TherapiesApr 12Sale326.707,5672,472,16439,713Apr 14 04:19 PM
Sanna BastianoEVP, Cell & Genetic TherapiesApr 04Sale315.81522164,85447,280Apr 06 04:23 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerMar 24Sale305.381,768539,91249,611Mar 28 04:13 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerMar 17Sale296.392,000592,78651,379Mar 21 04:21 PM
Sanna BastianoEVP, Cell & Genetic TherapiesMar 16Sale300.592,746825,42349,268Mar 20 04:26 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerMar 13Sale293.832,666783,34653,379Mar 14 04:22 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerMar 10Sale289.612,088604,70956,045Mar 14 04:22 PM
Arbuckle Stuart AEVP, COOFeb 27Sale287.475,0341,447,14356,556Feb 28 04:47 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 27Sale287.514,2381,218,44932,038Feb 28 04:40 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 27Sale287.551,207347,0727,303Feb 28 04:44 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 27Sale287.48354101,76856,805Feb 28 05:11 PM